152 related articles for article (PubMed ID: 31355166)
1. CD4
Zhang S; Goswami S; Ma J; Meng L; Wang Y; Zhu F; Zhang D; Zheng S; Dong R; Xiao X; Zhang X; Chen G
Front Pediatr; 2019; 7():279. PubMed ID: 31355166
[TBL] [Abstract][Full Text] [Related]
2. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
3. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
4. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
5. Frequency of infiltrating regulatory T-cells in the portal tract of biliary atresia.
Oita S; Saito T; Hashimoto R; Fumita T; Katsumata Y; Terui K; Komatsu S; Takenouchi A; Ikeda JI; Hishiki T
Pediatr Surg Int; 2023 Sep; 39(1):259. PubMed ID: 37656274
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and ICOS Antagonize Bim and Promote Regulatory T Cell Accrual with Age.
Raynor J; Karns R; Almanan M; Li KP; Divanovic S; Chougnet CA; Hildeman DA
J Immunol; 2015 Aug; 195(3):944-52. PubMed ID: 26109645
[TBL] [Abstract][Full Text] [Related]
7. Inducible Costimulator-C-X-C Motif Chemokine Receptor 3 Signaling is Involved in Chronic Obstructive Pulmonary Disease Pathogenesis.
Li DY; Chen L; Miao SY; Zhou M; Wu JH; Sun SW; Liu LL; Qi C; Xiong XZ
Int J Chron Obstruct Pulmon Dis; 2022; 17():1847-1861. PubMed ID: 35991707
[TBL] [Abstract][Full Text] [Related]
8. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
[TBL] [Abstract][Full Text] [Related]
9. IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.
Sim GC; Martin-Orozco N; Jin L; Yang Y; Wu S; Washington E; Sanders D; Lacey C; Wang Y; Vence L; Hwu P; Radvanyi L
J Clin Invest; 2014 Jan; 124(1):99-110. PubMed ID: 24292706
[TBL] [Abstract][Full Text] [Related]
10. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
11. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance.
Busse M; Krech M; Meyer-Bahlburg A; Hennig C; Hansen G
J Immunol; 2012 Aug; 189(4):1975-82. PubMed ID: 22815292
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
13. Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway.
Wen J; Zhou Y; Wang J; Chen J; Yan W; Wu J; Yan J; Zhou K; Xiao Y; Wang Y; Xia Q; Cai W
Cell Death Differ; 2017 Jun; 24(6):997-1006. PubMed ID: 28304404
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating mast cells stimulate ICOS
Lv Y; Tian W; Teng Y; Wang P; Zhao Y; Li Z; Tang S; Chen W; Xie R; Lü M; Zhuang Y
J Adv Res; 2024 Mar; 57():149-162. PubMed ID: 37086778
[TBL] [Abstract][Full Text] [Related]
15. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
[TBL] [Abstract][Full Text] [Related]
16. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
[TBL] [Abstract][Full Text] [Related]
17. The onset of active disease in systemic lupus erythematosus patients is characterised by excessive regulatory CD4+-T-cell differentiation.
Schaier M; Gottschalk C; Kälble F; Uhlmann L; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
Clin Exp Rheumatol; 2021; 39(2):279-288. PubMed ID: 32573411
[TBL] [Abstract][Full Text] [Related]
18. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
[TBL] [Abstract][Full Text] [Related]
19. Aberrant ICOS
Kälble F; Mai C; Wagner M; Schober L; Schaier M; Zeier M; Spratte J; Fluhr H; Steinborn A
Am J Reprod Immunol; 2016 Nov; 76(5):415-425. PubMed ID: 27650411
[TBL] [Abstract][Full Text] [Related]
20. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
